95
Views
1
CrossRef citations to date
0
Altmetric
Case Commentaries

Considerations for Unblinding in Biopharmaceutical Industry Sponsored Trials

&

References

  • Council for International Organizations of Medical Sciences. 2005. Management of safety information from clinical trials: Report of CIOMS working group VI. Geneva: Council for International Organizations of Medical Sciences.
  • U.S. Food and Drug Administration 2012. Safety reporting requirements for INDs and BA/BE studies. Guidance for industry and investigators. Rockville, MD: U.S. Department of Health and Human Services.
  • U.S. Food and Drug Administration 2015. Safety assessment for IND safety reporting. Guidance for industry and investigators. Rockville, MD: U.S. Department of Health and Human Services.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.